Diana L. Brixner
Impact in
- Economics and Econometrics top 2%
- Health Systems, Economic Evaluations, Quality of Life
- Pharmaceutical Economics and Policy
- Statistics and Probability top 5%
- Advanced Causal Inference Techniques
- Statistical Methods in Clinical Trials
Papers in
-
- Health Systems, Economic Evaluations, Quality of Life 10
- Pharmaceutical Economics and Policy 5
-
- Epilepsy research and treatment 2
- Co-authors
- Richard Willke (3 shared papers)Hans‐Georg Eichler (2 shared papers)Wim Goettsch (3 shared papers)Shirley V. Wang (3 shared papers)C. Daniel Mullins (3 shared papers)Marc L. Berger (3 shared papers)Amr Makady (3 shared papers)Rosanna Tarricone (3 shared papers)
- Journals
- Value in Health (9 papers)Journal of Managed Care & Specialty Pharmacy (6 papers)American Journal of Health-System Pharmacy (2 papers)Research in Social and Administrative Pharmacy (1 paper)Health Policy (1 paper)
- Partner nations
- United StatesAustriaNetherlands
In The Last Decade
Diana L. Brixner
35 papers receiving 1.1k citations
Diana L. Brixner's Hit Papers
Peers
Comparison fields: 5 of 75
- Economics and Econometrics 259
- Statistics and Probability 67
- Health Information Management 23
- Toxicology 9
- Endocrinology, Diabetes and Metabolism 38
Countries citing papers authored by Diana L. Brixner
This map shows the geographic impact of Diana L. Brixner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Diana L. Brixner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Diana L. Brixner more than expected).
Fields of papers citing papers by Diana L. Brixner
This network shows the impact of papers produced by Diana L. Brixner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Diana L. Brixner. The network helps show where Diana L. Brixner may publish in the future.
Co-authors
The 25 scholars most cited alongside Diana L. Brixner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 38 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Good Practices for Real‐World Data Studies of Treatment and/or Comparative Effectiveness: Recommendations from the Joint ISPOR‐ISPE Special Task Force on Real‐World Evidence in Health Care Decision Making Hit paper breakdown → | 2017 | 386 |
| 2 | 2017 | 272 | |
| 3 | 2015 | 117 | |
| 4 | 2009 | 103 | |
| 5 | 2020 | 73 | |
| 6 | 2009 | 46 | |
| 7 | 2018 | 29 | |
| 8 | 2014 | 17 | |
| 9 | 2004 | 14 | |
| 10 | 2009 | 13 | |
| 11 | Current and Future Use of HEOR Data in Healthcare Decision-Making in the United States and in Emerging Markets. | 2012 | 13 |
| 12 | 2021 | 9 | |
| 13 | 2013 | 8 | |
| 14 | 2018 | 7 | |
| 15 | Assessment of the prevalence and costs of osteoporosis treatment options in a real-world setting. | 2006 | 6 |
| 16 | 2019 | 6 | |
| 17 | 2013 | 4 | |
| 18 | 2017 | 4 | |
| 19 | 2014 | 3 | |
| 20 | 2024 | 3 |
About Diana L. Brixner
Diana L. Brixner is a scholar working on Economics and Econometrics, Psychiatry and Mental health, Endocrinology, Diabetes and Metabolism, Applied Microbiology and Biotechnology and Pharmacology, having authored 38 papers that have together received 1.2k indexed citations. Recurring topics across this work include Health Systems, Economic Evaluations, Quality of Life (10 papers), Pharmaceutical Economics and Policy (5 papers), Epilepsy research and treatment (2 papers), Diabetes Treatment and Management (2 papers), Lung Cancer Treatments and Mutations (1 paper), Bone health and osteoporosis research (1 paper), Blood Pressure and Hypertension Studies (1 paper) and HIV/AIDS Research and Interventions (1 paper). The work is most often cited by research in Economics and Econometrics (259 citations), Statistics and Probability (67 citations), Health Information Management (23 citations), Toxicology (9 citations) and Endocrinology, Diabetes and Metabolism (38 citations). Diana L. Brixner has collaborated with scholars based in United States, Austria and Netherlands. Frequent co-authors include Richard Willke, Hans‐Georg Eichler, Wim Goettsch, Shirley V. Wang, C. Daniel Mullins, Marc L. Berger, Amr Makady, Rosanna Tarricone, Harold C. Sox and Sebastian Schneeweiß. Their work appears in journals such as Value in Health, Journal of Managed Care & Specialty Pharmacy, American Journal of Health-System Pharmacy, Research in Social and Administrative Pharmacy and Health Policy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.